XTL Biopharmaceutica (Israel) Probability of Future Stock Price Finishing Over 10.01
| XTLB Stock | ILS 9.00 0.10 1.12% |
XTL |
XTL Biopharmaceutica Target Price Odds to finish over 10.01
The tendency of XTL Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over S 10.01 or more in 90 days |
| 9.00 | 90 days | 10.01 | about 6.47 |
Based on a normal probability distribution, the odds of XTL Biopharmaceutica to move over S 10.01 or more in 90 days from now is about 6.47 (This XTL Biopharmaceuticals probability density function shows the probability of XTL Stock to fall within a particular range of prices over 90 days) . Probability of XTL Biopharmaceuticals price to stay between its current price of S 9.00 and S 10.01 at the end of the 90-day period is about 5.26 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 3.74 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, XTL Biopharmaceutica will likely underperform. In addition to that XTL Biopharmaceuticals has an alpha of 2.3421, implying that it can generate a 2.34 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). XTL Biopharmaceutica Price Density |
| Price |
Predictive Modules for XTL Biopharmaceutica
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as XTL Biopharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of XTL Biopharmaceutica's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
XTL Biopharmaceutica Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. XTL Biopharmaceutica is not an exception. The market had few large corrections towards the XTL Biopharmaceutica's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold XTL Biopharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of XTL Biopharmaceutica within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 2.34 | |
β | Beta against NYSE Composite | 3.74 | |
σ | Overall volatility | 3.08 | |
Ir | Information ratio | 0.13 |
XTL Biopharmaceutica Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of XTL Biopharmaceutica for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for XTL Biopharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| XTL Biopharmaceutica is way too risky over 90 days horizon | |
| XTL Biopharmaceutica appears to be risky and price may revert if volatility continues | |
| XTL Biopharmaceutica has high likelihood to experience some financial distress in the next 2 years | |
| XTL Biopharmaceuticals has accumulated about 5.06 M in cash with (1.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 16.0% of the company outstanding shares are owned by insiders |
XTL Biopharmaceutica Technical Analysis
XTL Biopharmaceutica's future price can be derived by breaking down and analyzing its technical indicators over time. XTL Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of XTL Biopharmaceuticals. In general, you should focus on analyzing XTL Stock price patterns and their correlations with different microeconomic environments and drivers.
XTL Biopharmaceutica Predictive Forecast Models
XTL Biopharmaceutica's time-series forecasting models is one of many XTL Biopharmaceutica's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary XTL Biopharmaceutica's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about XTL Biopharmaceuticals
Checking the ongoing alerts about XTL Biopharmaceutica for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for XTL Biopharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| XTL Biopharmaceutica is way too risky over 90 days horizon | |
| XTL Biopharmaceutica appears to be risky and price may revert if volatility continues | |
| XTL Biopharmaceutica has high likelihood to experience some financial distress in the next 2 years | |
| XTL Biopharmaceuticals has accumulated about 5.06 M in cash with (1.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 16.0% of the company outstanding shares are owned by insiders |
Check out XTL Biopharmaceutica Backtesting, XTL Biopharmaceutica Valuation, XTL Biopharmaceutica Correlation, XTL Biopharmaceutica Hype Analysis, XTL Biopharmaceutica Volatility, XTL Biopharmaceutica History as well as XTL Biopharmaceutica Performance. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |